Jounce faces hos­tile takeover bid from mi­nor­i­ty stake­hold­er

Can­cer biotech Jounce Ther­a­peu­tics has got­ten a hos­tile takeover bid from Con­cen­tra Bio­sciences, a San Diego com­pa­ny backed by Tang Cap­i­tal Part­ners.

Tang Cap­i­tal is …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.